MedStar Health Announces MedStar Southern Maryland Hospital Center’s Recognition as a Center for Comprehensive Multiple Sclerosis Care
CLINTON, Md. - MedStar Southern Maryland Hospital Center has been designated as a Comprehensive Multiple Sclerosis (MS) Care Center through the National Multiple Sclerosis Society’s Partners in MS Care Program. MedStar Southern Maryland is the only hospital in Prince George’s County to receive this recognition, which is awarded to programs that demonstrate the highest level of knowledge and experience in treating MS, offer a full array of medical, nursing, mental health, rehabilitation, and social services, and have a strong collaborative relationship with the National MS Society.
“This significant recognition is a testament to the world-class care patients with MS receive at MedStar Southern Maryland,” said Chile Ahaghotu, MD, MBA, MHL, FACS, vice president of Medical Affairs and chief medical officer. “Our multidisciplinary team of neurological specialists and the commitment of our clinicians in providing comprehensive and cutting-edge MS care and therapies has a tremendous impact on the lives of patients in Southern Maryland.”
Advances in MS treatments and research are providing patients with the progressive and often disabling disease with new hope for an improved quality of life. Neurologists at MedStar Southern Maryland provide coordinated diagnosis and treatment for patients with MS, working closely with specialists at the renowned Multiple Sclerosis and Neuroimmunology Center at MedStar Georgetown University Hospital in Washington, D.C.
MedStar Southern Maryland Hospital Center’s neurology department, in partnership with the MedStar Health Research Institute, recently launched its new clinical trials program. The program is broadening access to critical clinical research studies for diseases with few or no available treatment options including MS. Patients eligible for clinical trials who were previously referred to the program at MedStar Georgetown can now access promising new treatments at MedStar Southern Maryland. The neurology clinical research program provides patients with new therapies still in trials as well as FDA-approved therapies not available at other community neurology programs.
For individuals living with and managing the symptoms of multiple sclerosis (MS), advanced infusion therapies, for example, are improving patients’ quality of life. Individuals who previously took MS medications every day or had to inject themselves with the drugs several times a week now receive effective treatment at MedStar Southern Maryland’s infusion center once or twice a year to prevent their MS from progressing.
“This designation as a Comprehensive Multiple Sclerosis Care Center by the National Multiple Sclerosis Society is a major milestone that marks the hospital’s vast capabilities to slow disease progression while offering a wide array of MS treatments,” added Stephen Michaels, MD, FAAOS, FACHE, president of MedStar Southern Maryland Hospital Center and senior vice president, MedStar Health. “I am extremely proud of this accomplishment and the dedication to individuals living with MS our providers display every day.”
Advances in MS treatments and research are providing patients with the progressive and often disabling disease with new hope for an improved quality of life. Neurologists at MedStar Southern Maryland provide coordinated diagnosis and treatment for patients with MS, working closely with specialists at the renowned Multiple Sclerosis and Neuroimmunology Center at MedStar Georgetown University Hospital in Washington, D.C.
MedStar Southern Maryland Hospital Center’s neurology department, in partnership with the MedStar Health Research Institute, recently launched its new clinical trials program. The program is broadening access to critical clinical research studies for diseases with few or no available treatment options including MS. Patients eligible for clinical trials who were previously referred to the program at MedStar Georgetown can now access promising new treatments at MedStar Southern Maryland. The neurology clinical research program provides patients with new therapies still in trials as well as FDA-approved therapies not available at other community neurology programs.
For individuals living with and managing the symptoms of multiple sclerosis (MS), advanced infusion therapies, for example, are improving patients’ quality of life. Individuals who previously took MS medications every day or had to inject themselves with the drugs several times a week now receive effective treatment at MedStar Southern Maryland’s infusion center once or twice a year to prevent their MS from progressing.
“This designation as a Comprehensive Multiple Sclerosis Care Center by the National Multiple Sclerosis Society is a major milestone that marks the hospital’s vast capabilities to slow disease progression while offering a wide array of MS treatments,” added Stephen Michaels, MD, FAAOS, FACHE, president of MedStar Southern Maryland Hospital Center and senior vice president, MedStar Health. “I am extremely proud of this accomplishment and the dedication to individuals living with MS our providers display every day.”
Categories
Media Contact
Cheryl Richardson
301-877-5556
cheryl.richardson@medstar.net